Public Health | December 11, 2021
Cipla aims to improve access to nebulisers in PHCs
The company will donate 5000 nebulizers to primary health care centres in rural India
The company will donate 5000 nebulizers to primary health care centres in rural India
The setting up of these 8 plants will lead to a total committed investment of Rs. 260.40 crore
It plans to add over 1000 employees over the next six months
As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them
It is an extension of GE Healthcare’s online service delivery enterprise Service Shop
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
MJ will be paid a one-time lumpsum licence fee of Rs 15 crore
Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively
Collectively, these 10 laboratories are capable of processing about 10,000 samples in a day and deliver results within the given turnaround time
Subscribe To Our Newsletter & Stay Updated
